ブログ

ブログ

Antibody specificity refers to an antibody's ability to selectively bind to a unique epitope on a target antigen while avoiding interactions with unrelated antigens. This property arises from the highly specialized antigen-binding site located in the variable region of the antibody, which determines its unique binding characteristics.

Dec 20, 2024

Antibody affinity refers to the strength of the binding interaction between a single antigen epitope and the paratope (binding site) of an antibody. This interaction is a fundamental measure of how well an antibody recognizes its specific antigen target.

Dec 20, 2024

Recombinant antibodies are produced using genetic engineering techniques, unlike traditional antibody production, where the immune system generates antibodies without direct control over their sequence. By introducing genes encoding antibody fragments into host cells, such as bacteria or mammalian cells, recombinant antibodies can be expressed, purified, and deployed for applications including research, diagnostics, and therapeutics.

Dec 19, 2024

Recombinant antibody expression is a biotechnological process that involves engineering and producing antibodies outside their natural context using recombinant DNA technology.

Dec 19, 2024

Proteins are synthesized as linear chains of amino acids, but their true functional complexity emerges after translation. Post-translational modifications (PTMs) introduce chemical changes to proteins, profoundly influencing their structure, function, and interactions. For antibodies, these modifications play a critical role in their diversity, specificity, and therapeutic potential.

Dec 18, 2024

Humanized monoclonal antibodies, derived from fully human sequences or engineered to resemble human antibodies, have addressed critical challenges of immunogenicity seen with earlier antibody therapies.

Dec 18, 2024

Monoclonal antibodies (mAbs) are engineered molecules designed to target specific antigens, such as those on pathogens or diseased cells. When these antibodies bind to their targets, they can activate immune responses to eliminate the threat. Traditional mAb development relied on hybridomas derived from animal cells, but these antibodies often elicited immune responses when introduced into humans due to their non-human origin.

Dec 17, 2024

On Friday December 13th, 2024, Biointron marked the end of a milestone year with a spectacular annual year-end networking party at Davio's Northern Italian Steakhouse in Boston. Bringing together industry professionals, partners, and clients, the event celebrated Biointron’s achievements and ho

Dec 16, 2024

Approved in 1998, trastuzumab (commonly known as Herceptin) marked a transformative milestone in oncology. Designed to target the human epidermal growth factor receptor 2 (HER2), trastuzumab provided a breakthrough for patients with HER2-positive breast cancer.

Dec 13, 2024

The development of custom antibodies is a critical component in advancing research and therapeutic innovation. Biointron, a Contract Research Organization (CRO) specializing in antibody expression services, provides comprehensive support to biotech companies seeking reliable, scalable, and high-quality solutions for their antibody production needs.

Dec 12, 2024

A vector is a molecular biology tool used to carry genetic material into a host cell. This genetic material, often a specific DNA sequence, can then be replicated, expressed, or analyzed within the host cell. Vectors are essential for a wide range of biotechnological applications, including protein expression, gene therapy, vaccine development, and genetic engineering.

Dec 11, 2024

T cells, also known as T lymphocytes, originate from stem cells in the bone marrow but mature in the thymus. These cells are essential in adaptive immunity, providing targeted responses to pathogens and abnormal cells, including cancer cells. Their ability to differentiate into diverse functional subsets makes them pivotal for maintaining immune balance, eliminating threats, and contributing to therapeutic strategies like immunotherapy.

Dec 10, 2024

最新情報を入手したい場合、ご登録をよろしくお願いいたします。

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。